JP2023533874A - Pn6047の塩酸塩の多形体 - Google Patents

Pn6047の塩酸塩の多形体 Download PDF

Info

Publication number
JP2023533874A
JP2023533874A JP2023503146A JP2023503146A JP2023533874A JP 2023533874 A JP2023533874 A JP 2023533874A JP 2023503146 A JP2023503146 A JP 2023503146A JP 2023503146 A JP2023503146 A JP 2023503146A JP 2023533874 A JP2023533874 A JP 2023533874A
Authority
JP
Japan
Prior art keywords
crystalline
hcl2
salt
hcl salt
hcl3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533874A5 (https=
Inventor
メンツァー,ベンクト フォン
ストレッケ,インゲマール
ジー ニルッソン,ハンス
Original Assignee
ファームノヴォ エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファームノヴォ エービー filed Critical ファームノヴォ エービー
Publication of JP2023533874A publication Critical patent/JP2023533874A/ja
Publication of JP2023533874A5 publication Critical patent/JP2023533874A5/ja
Priority to JP2025168607A priority Critical patent/JP2026016435A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2023503146A 2020-07-17 2021-07-12 Pn6047の塩酸塩の多形体 Pending JP2023533874A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025168607A JP2026016435A (ja) 2020-07-17 2025-10-06 Pn6047の塩酸塩の多形体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE2050910 2020-07-17
SE2050910-5 2020-07-17
PCT/EP2021/069340 WO2022013153A1 (en) 2020-07-17 2021-07-12 Polymorphs of a hydrochloride salt of pn6047

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025168607A Division JP2026016435A (ja) 2020-07-17 2025-10-06 Pn6047の塩酸塩の多形体

Publications (2)

Publication Number Publication Date
JP2023533874A true JP2023533874A (ja) 2023-08-04
JP2023533874A5 JP2023533874A5 (https=) 2024-05-15

Family

ID=77168220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023503146A Pending JP2023533874A (ja) 2020-07-17 2021-07-12 Pn6047の塩酸塩の多形体
JP2025168607A Pending JP2026016435A (ja) 2020-07-17 2025-10-06 Pn6047の塩酸塩の多形体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025168607A Pending JP2026016435A (ja) 2020-07-17 2025-10-06 Pn6047の塩酸塩の多形体

Country Status (7)

Country Link
US (1) US20230174525A1 (https=)
EP (1) EP4182312A1 (https=)
JP (2) JP2023533874A (https=)
CN (1) CN116171277B (https=)
AU (1) AU2021309364A1 (https=)
CA (1) CA3185973A1 (https=)
WO (1) WO2022013153A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501314A (ja) * 2014-12-19 2018-01-18 ファームノヴォ エービー ジアリールメチリデンピペリジン誘導体およびデルタオピオイド受容体アゴニストとしてそれらの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103313D0 (sv) * 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
US20110207745A1 (en) * 2009-11-25 2011-08-25 Astrazeneca Ab Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018501314A (ja) * 2014-12-19 2018-01-18 ファームノヴォ エービー ジアリールメチリデンピペリジン誘導体およびデルタオピオイド受容体アゴニストとしてそれらの使用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C.G.WERMUTH編, 最新 創薬化学 下巻, JPN6014029314, 1999, ISSN: 0005747387 *
芦澤一英, 医薬品の多形現象と晶析の科学, JPN6018028449, 2002, pages 56 - 102, ISSN: 0005747386 *

Also Published As

Publication number Publication date
CA3185973A1 (en) 2022-01-20
CN116171277B (zh) 2026-03-06
CN116171277A (zh) 2023-05-26
JP2026016435A (ja) 2026-02-03
EP4182312A1 (en) 2023-05-24
US20230174525A1 (en) 2023-06-08
AU2021309364A8 (en) 2023-03-16
AU2021309364A1 (en) 2023-02-16
WO2022013153A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
TWI846166B (zh) {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
US12365680B2 (en) Polymorphs of the hydrochloride salt of linaprazan glurate
EP2773620A1 (en) Ivabradine hydrochloride form iv
US20220002297A1 (en) Polymorphs of x842
JP2023548160A (ja) 1-(3-シアノ-1-イソプロピル-インドール-5-イル)ピラゾール-4-カルボン酸の結晶性粒子の製造方法およびそれを含む薬学的組成物
US20170226119A1 (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
JP2018515566A (ja) 医薬組成物
JP2023533874A (ja) Pn6047の塩酸塩の多形体
WO2007074477A2 (en) Metaxalone polymorphs
JP2018518515A (ja) フェニルアミノピリミジン化合物またはその塩の多形物
WO2024149834A1 (en) Polymorphs of the hydrobromide salt of linaprazan glurate
WO2023079093A1 (en) Polymorphs of the mesylate salt of linaprazan glurate
WO2023143427A1 (zh) Arv-110的晶型及其制备方法和用途
HK40092799A (zh) Pn6047盐酸盐的多晶型物
US9981912B2 (en) Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereof
WO2011027988A2 (en) Novel polymorphic form of prasugrel-hydrogen sulfate
US8258155B2 (en) Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
EP4649078A1 (en) Polymorphs of the maleic acid salt of linaprazan glurate
WO2022253261A1 (zh) Lazertinib甲磺酸盐的水合物晶型及其制备方法和用途
CN120518629A (zh) 一种维卡格雷的晶型及其制备方法和用途
WO2022263899A1 (en) Novel manufacturing method of daprodustat and precursors thereof
HK1213549B (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230824

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250404

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251006